1.1                          A bill for an act 
  1.2             relating to crime prevention; classifying Gamma 
  1.3             Hydroxybutyrate as a controlled substance; amending 
  1.4             Minnesota Statutes 1998, section 152.02, subdivision 4.
  1.5   BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: 
  1.6      Section 1.  Minnesota Statutes 1998, section 152.02, 
  1.7   subdivision 4, is amended to read: 
  1.8      Subd. 4.  [SCHEDULE III.] The following items are listed in 
  1.9   Schedule III:  
  1.10     (1) Any material, compound, mixture, or preparation which 
  1.11  contains any quantity of Amphetamine, its salts, optical 
  1.12  isomers, and salts of its optical isomers; Phenmetrazine and its 
  1.13  salts; Methamphetamine, its salts, isomers, and salts of 
  1.14  isomers; Methylphenidate; and which is required by federal law 
  1.15  to be labeled with the symbol prescribed by 21 Code of Federal 
  1.16  Regulations Section 1302.03 and in effect on February 1, 1976 
  1.17  designating that the drug is listed as a Schedule III controlled 
  1.18  substance under federal law.  
  1.19     (2) Any material, compound, mixture, or preparation which 
  1.20  contains any quantity of the following substances having a 
  1.21  potential for abuse associated with a depressant effect on the 
  1.22  central nervous system:  
  1.23     (a) Any compound, mixture, or preparation containing 
  1.24  amobarbital, secobarbital, pentobarbital or any salt thereof and 
  1.25  one or more other active medicinal ingredients which are not 
  2.1   listed in any schedule.  
  2.2      (b) Any suppository dosage form containing amobarbital, 
  2.3   secobarbital, pentobarbital, or any salt of any of these drugs 
  2.4   and approved by the food and drug administration for marketing 
  2.5   only as a suppository.  
  2.6      (c) Any substance which contains any quantity of a 
  2.7   derivative of barbituric acid, or any salt of a derivative of 
  2.8   barbituric acid, except those substances which are specifically 
  2.9   listed in other schedules:  Chlorhexadol; Glutethimide; Lysergic 
  2.10  acid; Lysergic acid amide; Methyprylon; Sulfondiethylmethane; 
  2.11  Sulfonethylmethane; Sulfonmethane. 
  2.12     (d) Gamma hydroxybutyrate, any salt, compound, derivative, 
  2.13  or preparation of gamma hydroxybutyrate, including any isomers, 
  2.14  esters, and ethers and salts of isomers, esters, and ethers of 
  2.15  gamma hydroxybutyrate whenever the existence of such isomers, 
  2.16  esters, and salts is possible within the specific chemical 
  2.17  designation.  
  2.18     (3) Any material, compound, mixture, or preparation which 
  2.19  contains any quantity of the following substances having a 
  2.20  potential for abuse associated with a stimulant effect on the 
  2.21  central nervous system:  
  2.22     (a) Benzphetamine 
  2.23     (b) Chlorphentermine 
  2.24     (c) Clortermine 
  2.25     (d) Mazindol 
  2.26     (e) Phendimetrazine.  
  2.27     (4) Nalorphine.  
  2.28     (5) Any material, compound, mixture, or preparation 
  2.29  containing limited quantities of any of the following narcotic 
  2.30  drugs, or any salts thereof:  
  2.31     (a) Not more than 1.80 grams of codeine per 100 
  2.32  milliliters or not more than 90 milligrams per dosage unit, with 
  2.33  an equal or greater quantity of an isoquinoline alkaloid of 
  2.34  opium.  
  2.35     (b) Not more than 1.80 grams of codeine per 100 
  2.36  milliliters or not more than 90 milligrams per dosage unit, with 
  3.1   one or more active, nonnarcotic ingredients in recognized 
  3.2   therapeutic amounts.  
  3.3      (c) Not more than 300 milligrams of dihydrocodeinone per 
  3.4   100 milliliters or not more than 15 milligrams per dosage unit, 
  3.5   with a fourfold or greater quantity of an isoquinoline alkaloid 
  3.6   of opium.  
  3.7      (d) Not more than 300 milligrams of dihydrocodeinone per 
  3.8   100 milliliters or not more than 15 milligrams per dosage unit, 
  3.9   with one or more active, nonnarcotic ingredients in recognized 
  3.10  therapeutic amounts. 
  3.11     (e) Not more than 1.80 grams of dihydrocodeine per 100 
  3.12  milliliters or not more than 90 milligrams per dosage unit, with 
  3.13  one or more active, nonnarcotic ingredients in recognized 
  3.14  therapeutic amounts.  
  3.15     (f) Not more than 300 milligrams of ethylmorphine per 100 
  3.16  milliliters or not more than 15 milligrams per dosage unit, with 
  3.17  one or more active, nonnarcotic ingredients in recognized 
  3.18  therapeutic amounts.  
  3.19     (g) Not more than 500 milligrams of opium per 100 
  3.20  milliliters or per 100 grams, or not more than 25 milligrams per 
  3.21  dosage unit, with one or more active, nonnarcotic ingredients in 
  3.22  recognized therapeutic amounts. 
  3.23     (h) Not more than 50 milligrams of morphine per 100 
  3.24  milliliters or per 100 grams with one or more active, 
  3.25  nonnarcotic ingredients in recognized therapeutic amounts. 
  3.26     Sec. 2.  [EFFECTIVE DATE.] 
  3.27     Section 1 is effective August 1, 1999, and applies to 
  3.28  crimes committed on or after that date.